Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Type 1 Interferon Promotes RBC Alloimmunization in a Lupus Mouse Model

Najwa EL Kadi, PhD BS, MS, Emaan Madany, BS, Kessandra NG, Sumaarg Pandya, Caroline Jefferies, PhD, David R Gibb, MD PhD

Blood (2019) 134 (Supplement_1): 101.

https://doi.org/10.1182/blood-2019-130903

Published: 2019

Journal Articles

CD47 Regulates Red Blood Cell Alloimmunization in Mice

Ryan Jajosky, MD, Connie Arthur, PhD, Jerry Allen, BS, Megan Fuller, BS, Patricia E Zerra, MD, Cheryl Maier, MD PhD, Sean R. Stowell, MD PhD

Blood (2019) 134 (Supplement_1): 100.

https://doi.org/10.1182/blood-2019-131598

Published: 2019

Journal Articles

An Update on Safety and Preliminary Efficacy of Highly Specific Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Combination with PD-1 Inhibitor Tislelizumab in Patients with Previously Treated B-Cell Lymphoid Malignancies

Constantine S. Tam, MBBS, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Stephen Opat, Gareth P Gregory, MBBS (Hons), PhD FRACP, FRCPA, Aichun Liu, MD, Anna M. Johnston, Weili Zhao, MD PhD, Fernando Roncolato, BMed, FRACP, FRCPA, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, H. Miles Prince, MBBS (Hons), MD FRACP, FRCPA, AFRCMA, MACD, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Wenyu Li, MD PhD, Ted Shih, PharmD, Xiaoping Zhang, MD MS, Ken Wu, PhD, Yuan Liu, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA

Blood (2019) 134 (Supplement_1): 1594.

https://doi.org/10.1182/blood-2019-125485

Published: 2019

Journal Articles

Preoperative Transfusion in Pediatric Patient with Sickle Cell Disease

Mohamed Al Darwish, Sukainah Alabkary, Hajer Al deabel, Fatimah Alqatari, Wafa AlDubaisy

Blood (2019) 134 (Supplement_1): 4851.

https://doi.org/10.1182/blood-2019-127104

Published: 2019

Journal Articles

Increased Expression of Type 1 Interferon Stimulated Genes in Sickle Cell Disease and a Potential Association with RBC Alloimmunization

Emaan Madany, BS, Najwa El Kadi, PhD, Sumaarg Pandya, Jeanne E. Hendrickson, MD, David R Gibb, MD PhD

Blood (2019) 134 (Supplement_1): 716.

https://doi.org/10.1182/blood-2019-124899

Published: 2019

Journal Articles

Red Blood Cell and Platelet Phenotype Prediction from Whole Genome Sequencing in 621 Sickle Cell Disease Patients: Correlation with Alloimmunization History, Serology and Other Genotyping Methods

Celina Montemayor Garcia, MD PhD, Julie K. Weisman, MD, Divya Gandla, James Owen Long, MD, Clifton Lee Dalgard, PhD CLS, Mehdi Pirooznia, MD PhD, Harvey Klein, MD, Swee Lay Thein, DSc, FRCP, FRCPath, MBBS, MRCPath, MRCP

Blood (2018) 132 (Supplement 1): 2388.

https://doi.org/10.1182/blood-2018-99-115008

Published: 2018

Journal Articles

Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Combination with the PD-1 Inhibitor BGB-A317 in Patients with B-Cell Lymphoid Malignancies

Gavin Cull, MB, BS, FRACP, FRCPA, Stephen Opat, FRACP, FRCPA, Judith Trotman, MBChB, FRACP, FRCPA, James Hilger, Xiaoping Zhang, Shibao Feng, PhD, Sunhee Ro, PhD, Jane Huang, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 4057.

https://doi.org/10.1182/blood.V130.Suppl_1.4057.4057

Published: 2017

Journal Articles

Antigen-Mediated Immune Suppression Is Antigen Specific

Cheryl Maier, MD PhD, Amanda Mener, Seema R Patel, BS, PhD, Ashley L Bennett, BA, Sean R Stowell, MD PhD

Blood (2017) 130 (Supplement 1): 708.

https://doi.org/10.1182/blood.V130.Suppl_1.708.708

Published: 2017

Journal Articles

Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4 + T Cell Activation

Patricia E Zerra, MD, Seema R Patel, BS, PhD, Ashley L Bennett, BA, Sean R Stowell, MD PhD

Blood (2017) 130 (Supplement 1): 2399.

https://doi.org/10.1182/blood.V130.Suppl_1.2399.2399

Published: 2017

Journal Articles

Immunohematology and Transfusion Support of a Patient with Acute Myeloid Leukemia and an Anti-Vel

Jennifer J. O'Brien, MD PhD, Najeebah A. Bade, MD BS, BA, Agnes Hallie Lee-Stroka, Sakhone B. Learn, Sandra Nance, Christine A. Tremblay, Heather L. McGann, Patricia A. R. Brunker, MD DPhil, Nancy M. Hardy, MD, Maria R. Baer, MD, Magali J. Fontaine, MD PhD

Blood (2017) 130 (Supplement 1): 4932.

https://doi.org/10.1182/blood.V130.Suppl_1.4932.4932

Published: 2017

Journal Articles

Autoimmune Hemolytic Anemia and Hemolytic Transfusion Reactions in Two Patients with Waldenström Macroglobulinemia Treated with Combination BTK Inhibitor and PD-1 Inhibitor

Jad Othman, MBBS, Emma Verner, FRACP,FRCPA,MBBS, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Jane Huang, MD, Leo Lin, MD, James Hilger, Judith Trotman, FRACP, Robin E Gasiorowski

Blood (2017) 130 (Supplement 1): 5153.

https://doi.org/10.1182/blood.V130.Suppl_1.5153.5153

Published: 2017

Journal Articles

The Effect of ABO Immune Complexes on Endothelial Cell Integrity As Measured By Electric Cell-Substrate Impedance Sensing (ECIS) and Confocal Microscopy

Hannah L McRae, Spencer Slavin, B.S., Arshad Rahman, PhD, Neil Blumberg, MD, Majed A Refaai, MD

Blood (2017) 130 (Supplement 1): 2306.

https://doi.org/10.1182/blood.V130.Suppl_1.2306.2306

Published: 2017

Journal Articles

Inpatient Non-Hemolytic Delayed Serologic Transfusion Reactions and Hospital Length of Stay: Is There an Association?

Matthew Yan, MD, Christine Cserti-Gazdewich, MD

Blood (2016) 128 (22): 2633.

https://doi.org/10.1182/blood.V128.22.2633.2633

Published: 2016

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

Eiran Warner, MD BA, Catherine Broome, MD

Blood (2016) 128 (22): 3843.

https://doi.org/10.1182/blood.V128.22.3843.3843

Published: 2016

Journal Articles

C3 Modulates RBC Antigen to Negatively Regulate Antibody Response

Amanda Mener, Connie M. Arthur, PhD, Seema R. Patel, PhD, Sean R. Stowell, MD PhD

Blood (2016) 128 (22): 22.

https://doi.org/10.1182/blood.V128.22.22.22

Published: 2016

Journal Articles

Clearance of Incompatible RBC Is Compromised during Persistent Viral Infection

Connie Maridith Arthur, PhD, Andreas Weiland, PhD, Harold Clifford Sullivan, MD, Rafi Ahmed, PhD, Sean R. Stowell, MD PhD

Blood (2015) 126 (23): 1149.

https://doi.org/10.1182/blood.V126.23.1149.1149

Published: 2015

Journal Articles

Antigen Density Impacts RBC Survival and Antigen Modulation Following Incompatible RBC Transfusion

Justin Yoo, BS, MS, Connie Maridith Arthur, PhD, Patricia Zerra, MD, Kathryn Girard-Pierce, Jeanne E. Hendrickson, MD, Sean R. Stowell, MD PhD

Blood (2015) 126 (23): 2350.

https://doi.org/10.1182/blood.V126.23.2350.2350

Published: 2015

Journal Articles

High Percentage of Evanescent Red Cell Antibodies in Patients with Sickle Cell Disease Highlights the Need for a National Antibody Database

Marisa B Marques, MD, Robinna G Lorenz, MDPhD, Lance A Williams, MD

Blood (2015) 126 (23): 3572.

https://doi.org/10.1182/blood.V126.23.3572.3572

Published: 2015

Journal Articles

Red Cell Antigen Genotyping Compared to Standard Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization

Khalid S Al-Habsi, MD FRCPath, Andrew W. Shih, MD BSc, Rebecca Barty, MLT, CTRC, Grace Wang, Allahna Elahie, MLT, Mona Azzam, MD, Reda Siddiqui, Michael Parvizian, Nancy M Heddle, MSc, Uma H. Athale, MD, M.Sc., Mindy Rona Goldman, MD FRCP(C), Madeleine M Verhovsek, BSc, MD FRCPC

Blood (2015) 126 (23): 3404.

https://doi.org/10.1182/blood.V126.23.3404.3404

Published: 2015

Journal Articles

Alloantibody Formation In Sickle Cell Disease

Joep Sins, MD, MSc, Saurabh Zalpuri, MD, PhD, Marjon Cnossen, MD, PhD, Anita W. Rijneveld, MD, PhD, Jean-Louis Kerkhoffs, MD, PhD, Alfred van Meurs, MD, Yolanda de Rijke, PhD, Marjolein Peters, MD, PhD, Bart J. Biemond, MD, PhD, Anske van der Bom, MD, PhD, Karin Fijnvandraat, MD, PhD

Blood (2013) 122 (21): 2395.

https://doi.org/10.1182/blood.V122.21.2395.2395

Published: 2013

NARROW

Type 1 Interferon Promotes RBC Alloimmunization in a Lupus Mouse Model

CD47 Regulates Red Blood Cell Alloimmunization in Mice

An Update on Safety and Preliminary Efficacy of Highly Specific Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Combination with PD-1 Inhibitor Tislelizumab in Patients with Previously Treated B-Cell Lymphoid Malignancies

Preoperative Transfusion in Pediatric Patient with Sickle Cell Disease

Increased Expression of Type 1 Interferon Stimulated Genes in Sickle Cell Disease and a Potential Association with RBC Alloimmunization

Red Blood Cell and Platelet Phenotype Prediction from Whole Genome Sequencing in 621 Sickle Cell Disease Patients: Correlation with Alloimmunization History, Serology and Other Genotyping Methods

Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Combination with the PD-1 Inhibitor BGB-A317 in Patients with B-Cell Lymphoid Malignancies

Antigen-Mediated Immune Suppression Is Antigen Specific

Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4 + T Cell Activation

Immunohematology and Transfusion Support of a Patient with Acute Myeloid Leukemia and an Anti-Vel

Autoimmune Hemolytic Anemia and Hemolytic Transfusion Reactions in Two Patients with Waldenström Macroglobulinemia Treated with Combination BTK Inhibitor and PD-1 Inhibitor

The Effect of ABO Immune Complexes on Endothelial Cell Integrity As Measured By Electric Cell-Substrate Impedance Sensing (ECIS) and Confocal Microscopy

Inpatient Non-Hemolytic Delayed Serologic Transfusion Reactions and Hospital Length of Stay: Is There an Association?

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

C3 Modulates RBC Antigen to Negatively Regulate Antibody Response

Clearance of Incompatible RBC Is Compromised during Persistent Viral Infection

Antigen Density Impacts RBC Survival and Antigen Modulation Following Incompatible RBC Transfusion

High Percentage of Evanescent Red Cell Antibodies in Patients with Sickle Cell Disease Highlights the Need for a National Antibody Database

Red Cell Antigen Genotyping Compared to Standard Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization

Alloantibody Formation In Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only